Brief Report-Reference-Cited by-同舟云学术

Brief Report

Published:2015-12-15 Issue:5 Volume:70 Page:515-519
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Walmsley Sharon,Baumgarten Axel,Berenguer Juan,Felizarta Franco,Florence Eric,Khuong-Josses Marie-Aude,Kilby J. Michael,Lutz Thomas,Podzamczer Daniel,Portilla Joaquin,Roth Norman,Wong Deborah,Granier Catherine,Wynne Brian,Pappa Keith

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference5 articles.

1. . Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection.;Walmsley;N Engl J Med,2013

2. . Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING study.;Eron;J Infect Dis,2013

3. . Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.;Raffi;Lancet,2013

4. . Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.;Stellbrink;AIDS,2013

5. . Once daily dolutegravir (SGSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial.;van Lunzen;Lancet Infect Dis,2012

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa;Journal of the International AIDS Society;2024-07

3. Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial;International Journal of Antimicrobial Agents;2024-06

4. Liver function tests, CD4+ counts, and viral load among people living with HIV on dolutegravir compared to efavirenz-based cART; a comparative cross-sectional study;Heliyon;2024-06

5. Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi;BMC Public Health;2024-05-16